Immediate Impact
1 by Nobel laureates 5 from Science/Nature 53 standout
Citing Papers
Natural killer cell therapies
2024 StandoutNature
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
2023 Standout
Works of Tünde Nagy being referenced
Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: A phase 2 study
2013
Receptor-like properties of the 26 kDa transmembrane form of TNF.
2002
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Tünde Nagy | 363 | 143 | 324 | 43 | 919 | |
| Yi Miao | 205 | 47 | 445 | 30 | 820 | |
| E. D. Wachsmuth | 239 | 50 | 549 | 65 | 1.0k | |
| Agnes Dadak | 90 | 59 | 527 | 28 | 1.1k | |
| R. G. Butcher | 100 | 76 | 373 | 36 | 937 | |
| E. Verney | 129 | 132 | 486 | 47 | 1.1k | |
| Katalin Goda | 492 | 79 | 492 | 44 | 1.0k | |
| Charles S. Schasteen | 160 | 39 | 428 | 25 | 1.1k | |
| Young‐Jin Kim | 336 | 75 | 625 | 47 | 1.1k | |
| Raju Das | 68 | 68 | 234 | 52 | 962 | |
| Mina Yang | 114 | 57 | 480 | 37 | 993 |
All Works
Login with ORCID to disown or claim papers
Loading papers...